75 related articles for article (PubMed ID: 16259635)
1. Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.
Moreno-Luna LE; Arrieta O; García-Leiva J; Martínez B; Torre A; Uribe M; León-Rodríguez E
BMC Cancer; 2005 Oct; 5():142. PubMed ID: 16259635
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective.
Mayo SC; Mavros MN; Nathan H; Cosgrove D; Herman JM; Kamel I; Anders RA; Pawlik TM
J Am Coll Surg; 2014 Feb; 218(2):196-205. PubMed ID: 24315886
[TBL] [Abstract][Full Text] [Related]
3. Genomic Variations Between Fibrolamellar and Conventional Hepatocellular Carcinomas.
Öztürk B
Cureus; 2023 Dec; 15(12):e50795. PubMed ID: 38116022
[TBL] [Abstract][Full Text] [Related]
4. Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report.
Na SK
J Liver Cancer; 2022 Sep; 22(2):178-182. PubMed ID: 37383417
[TBL] [Abstract][Full Text] [Related]
5. Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma.
Simon SM
Nat Rev Cancer; 2023 May; 23(5):335-346. PubMed ID: 36932129
[TBL] [Abstract][Full Text] [Related]
6. Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event.
Abdelhamed W; El-Kassas M
World J Gastrointest Oncol; 2022 Jun; 14(6):1103-1114. PubMed ID: 35949219
[TBL] [Abstract][Full Text] [Related]
7. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study.
Sempokuya T; Forlemu A; Azawi M; Silangcruz K; Khoury N; Ma J; Wong LL
World J Clin Oncol; 2022 May; 13(5):352-365. PubMed ID: 35662983
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver.
El Dika I; Bowman AS; Berger MF; Capanu M; Chou JF; Benayed R; Zehir A; Shia J; O'Reilly EM; Klimstra DS; Solit DB; Abou-Alfa GK
Cancer; 2020 Sep; 126(18):4126-4135. PubMed ID: 32663328
[TBL] [Abstract][Full Text] [Related]
9. A prognostic nomogram for patients with resected fibrolamellar hepatocellular carcinoma.
Lafaro KJ; Eng OS; Raoof M; Ituarte P; Warner SG; Singh G; Fong Y; Melstrom LG
Hepatobiliary Surg Nutr; 2019 Aug; 8(4):338-344. PubMed ID: 31489303
[TBL] [Abstract][Full Text] [Related]
10. Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.
Lalazar G; Simon SM
Semin Liver Dis; 2018 Feb; 38(1):51-59. PubMed ID: 29471565
[TBL] [Abstract][Full Text] [Related]
11. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification.
Jiang K; Al-Diffhala S; Centeno BA
Cancer Control; 2018; 25(1):1073274817744625. PubMed ID: 29350068
[TBL] [Abstract][Full Text] [Related]
12. Fibrolamellar hepatocellular carcinoma: current clinical perspectives.
Lafaro KJ; Pawlik TM
J Hepatocell Carcinoma; 2015; 2():151-7. PubMed ID: 27508204
[TBL] [Abstract][Full Text] [Related]
13. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments.
Kassahun WT
World J Surg Oncol; 2016 May; 14(1):151. PubMed ID: 27215576
[TBL] [Abstract][Full Text] [Related]
14. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.
Chagas AL; Kikuchi L; Herman P; Alencar RS; Tani CM; Diniz MA; Pugliese V; Rocha Mde S; D'Albuquerque LA; Carrilho FJ; Alves VA
Clinics (Sao Paulo); 2015 Mar; 70(3):207-13. PubMed ID: 26017653
[TBL] [Abstract][Full Text] [Related]
16. Case 1-2011: a 26 year-old man with right lower limb edema and liver mass.
Taslimi R; Malekzadeh R; Rahmani M; Azmodeh Ardalan F
Middle East J Dig Dis; 2011 Mar; 3(1):62-71. PubMed ID: 25197535
[No Abstract] [Full Text] [Related]
17. CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients.
Do RK; McErlean A; Ang CS; DeMatteo RP; Abou-Alfa GK
Br J Radiol; 2014 Aug; 87(1040):20140024. PubMed ID: 24896196
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for malignancies.
Eghtesad B; Aucejo F
J Gastrointest Cancer; 2014 Sep; 45(3):353-62. PubMed ID: 24604263
[TBL] [Abstract][Full Text] [Related]
19. Fibrolamellar carcinoma: 2012 update.
Torbenson M
Scientifica (Cairo); 2012; 2012():743790. PubMed ID: 24278737
[TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.
Kaseb AO; Shama M; Sahin IH; Nooka A; Hassabo HM; Vauthey JN; Aloia T; Abbruzzese JL; Subbiah IM; Janku F; Curley S; Hassan MM
Oncology; 2013; 85(4):197-203. PubMed ID: 24051705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
